Hepatitis C virus infection among drug injectors in St Petersburg, Russia: Social and molecular epidemiology of an endemic infection

Addiction

Volumn 104, Issue 11, 2009, Pages 1881-1890

  Paintsil, Elijah ^a   Verevochkin, Sergei V ^b   Dukhovlinova, Elena ^b   Niccolai, Linda ^c   Barbour, Russell ^c   White, Edward ^c   Toussova, Olga V ^b   Alexander, Louis ^c   Kozlov, Andrei P ^b   Heimer, Robert ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Biomedical Center   (Russian Federation)

^c YALE UNIVERSITY   (United States)

Author keywords

Genotyping; HCV; Injection drug users; Molecular epidemiology; Respondent driven sampling; Russia; Social network

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; DRUG ABUSE; ENDEMIC DISEASE; FEMALE; GENETIC LINKAGE; GENOTYPE; HEPATITIS C; HUMAN; INJECTION DRUG USER; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MOLECULAR EPIDEMIOLOGY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RUSSIAN FEDERATION; SAMPLING; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SEXUAL BEHAVIOR;

ADOLESCENT; ADULT; CONTACT TRACING; CROSS-SECTIONAL STUDIES; ENDEMIC DISEASES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PREVALENCE; RNA, VIRAL; RUSSIA; SEXUAL BEHAVIOR; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 70349862205     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02687.x     Document Type: Article

References (68)

1. Cohen J. The scientific challenge of hepatitis C. Science 1999 285 : 26 30.
2. Alter M. J. Prevention of spread of hepatitis C. Hepatology 2002 36 : S93 8.
3. Lauer G. M., Walker B. D. Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52.
4. Hagan H., Thiede H., Weiss N. S., Hopkins S. G., Duchin J. S., Alexander E. R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001 91 : 42 6.
5. Chaisson R. E., Bacchetti P., Osmond D., Brodie B., Sande M. A., Moss A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989 261 : 561 565.
6. Thorpe L. E., Ouellet L. J., Hershow R., Bailey S. L., Williams I. T., Williamson J. et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002 155 : 645 653.
7. Koester S., Glanz J., Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav 2005 9 : 27 39.
8. Dehne K. L., Khodakevich L., Hamers F. F., Schwartlander B. The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implications for policy-making. Aids 1999 13 : 741 749. (Pubitemid 29224575)
9. Kalichman S. C., Kelly J. A., Sikkema K. J., Koslov A. P., Shaboltas A., Granskaya J. The emerging AIDS crisis in Russia: review of enabling factors and prevention needs. Int J STD AIDS 2000 11 : 71 5.
10. Atlani L., Carael M., Brunet J. B., Frasca T., Chaika N. Social change and HIV in the former USSR: the making of a new epidemic. Soc Sci Med 2000 50 : 1547 1556.
11. Poznyak V. B., Pelipas V. E., Vievski A. N., Miroshnichenko L. Illicit drug use and its health consequences in Belarus, Russian Federation and Ukraine: impact of transition. Eur Addict Res 2002 8 : 184 189.
12. Rhodes T., Sarang A., Bobrik A., Bobkov A., Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy 2004 15 : 1 16.
13. Heimer R., Grau L. E., Curtin E., Khoshnood K., Singer M. Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts. Am J Public Health 2007 97 : 110 116.
14. Rhodes T., Platt L., Judd A., Mikhailova L. A., Sarang A., Wallis N. et al. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia. Int J STD AIDS 2005 16 : 749 754.
15. Rhodes T., Platt L., Maximova S., Koshkina E., Latishevskaya N., Hickman M. et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 2006 101 : 252 266.
16. Shustov A. V., Kochneva G. V., Sivolobova G. F., Grazhdantseva A. A., Gavrilova I. V., Akinfeeva L. A. et al. Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol 2005 77 : 382 389.
17. Aral S. O., St Lawrence J. S., Dyatlov R., Kozlov A. Commercial sex work, drug use, and sexually transmitted infections in St. Petersburg, Russia. Soc Sci Med 2005 60 : 2181 2190.
18. AIDS Foundation East-West (AFEW). Russian Federation. Moscow, RF; AFEW: 2008. Available at: http://www.afew.org (accessed 3 April 2009).
19. Abdala N., Carney J. M., Durante A. J., Klimov N., Ostrovski D., Somlai A. M. et al. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. Int J STD AIDS 2003 14 : 697 703.
20. Kalinina O., Norder H., Vetrov T., Zhdanov K., Barzunova M., Plotnikova V. et al. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 2001 65 : 517 524.
21. Magnani R., Sabin K., Saidel T., Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. Aids 2005 19 : S67 72.
22. Abdul-Quader A. S., Heckathorn D. D., McKnight C., Bramson H., Nemeth C., Sabin K. et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health 2006 83 : 459 476. (Pubitemid 44341557)
23. Simmonds P., Holmes E. C., Cha T. A., Chan S. W., McOmish F., Irvine B. et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993 74 : 2391 2399.
24. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C. et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991 88 : 2451 2455.
25. Pawlotsky J. M. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 2003 7 : 45 66.
26. López-Labrador F. X., Ampurdanès S., Giménez-Barcons M., Guilera M., Costa J., Jiménez de Anta M. T. et al. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 1999 29 : 897 903.
27. Hadziyannis S. J., Koskinas J. S. Differences in epidemiology, liver disease and treatment response among HCV genotypes. Hepatol Res 2004 29 : 129 135.
28. Hnatyszyn H. J. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005 10 : 1 11.
29. Nunez M., Soriano V. Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients. J Infect Dis 2005 191 : 1 3. (Pubitemid 40041392)
30. Soriano V., Núñez M., Sánchez-Conde M., Barreiro P., García-Samaniego J., Martín-Carbonero L. et al. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4. Antivir Ther 2005 10 : 167 170. (Pubitemid 40767642)
31. Hopf U., Berg T., König V., Küther S., Heuft H. G., Lobeck H. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes. J Hepatol 1996 24 : 67 73.
32. Kobayashi M., Tanaka E., Sodeyama T., Urushihara A., Matsumoto A., Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996 23 : 695 699.
33. Friedman S. R., Neaigus A., Jose B., Curtis R., Goldstein M., Ildefonso G. et al. Sociometric risk networks and HIV risk. Am J Public Health 1997 87 : 1289 1296.
34. Potterat J. J., Phillips-Plummer L., Muth S. Q., Rothenberg R. B., Woodhouse D. E., Maldonado-Long T. S. et al. Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs. Sex Transm Infect 2002 78 : 159 163.
35. Rothenberg R. B., Long D. M., Sterk C. E., Pach A., Potterat J. J., Muth S. et al. The Atlanta Urban Networks Study: a blueprint for endemic transmission. AIDS 2000 14 : 2191 2200.
36. Latkin C. A., Forman V., Knowlton A., Sherman S. Norms, social networks and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med 2003 56 : 465 476.
37. Iguchi M. Y., Ober A. J., Berry S. H., Fain T., Heckathorn D. D., Gorbach P. M. et al. Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent driven sampling: sampling methods and implications. J Urban Health 2009 DOI 10.1007/s11524-009-9365-4. Available at: http://www.springerlink.com/content/2u2551q0134h76x7 (accessed 3 April 2009).
38. Niccolai L. M., Toussova O. V., Verevochkin S. V., Barbour R., Heimer R., Kozlov A. P. High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav, 2009. Available at: http://www.springerlink.com/content/104828/?k= Niccolai (accessed 3 April 2009).
39. Chesney M. A., Koblin B. A., Barresi P. J., Husnik M. J., Celum C. L., Colfax G. et al. An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study. Am J Public Health 2003 93 : 933 938.
40. Gorbach P. M., Drumright L. N., Daar E. S., Little S. J. Transmission behaviors of recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr 2006 42 : 80 5.
41. Mansergh G., Flores S., Koblin B., Hudson S., McKirnan D., Colfax G. N. Alcohol and drug use in the context of anal sex and other factors associated with sexually transmitted infections: results from a multi-city study of high-risk men who have sex with men in the USA. Sex Transm Infect 2008 84 : 509 511.
42. National Institute on Drug Abuse (NIDA). Risk Behavior Assessment. Rockville, MD : NIDA/NIH/DHHS 1991.
43. Needle R., Fisher D. G., Weatherby N., Chitwood D., Brown B. l., Cesari H. et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav 1995 9 : 242 250.
44. Shehan D. A., LaLota M., Johnson D. F., Celentano D. D., Koblin B. A., Torian L. V. et al. HIV/STD risks in young men who have sex with men who do not disclose their sexual orientation - six U.S. cities, 1994-2000. MMWR 2003 52 : 81 5.
45. Ohno O., Mizokami M., Wu R. R., Saleh M. G., Ohba K., Orito E. et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997 35 : 201 207.
46. Higgins D. G., Bleasby A. J., Fuchs R. CLUSTAL V: improved software for multiple sequence alignment. Comput Appl Biosci 1992 8 : 189 191.
47. Onishchenko G. G., Shakhgil'dian I. V. The current problems in the epidemiology and prevention of viral hepatitis B and C in the Russian Federation. Zh Mikrobiol Epidemiol Immunobiol 2000 50 4.
48. Hope V. D., Judd A., Hickman M., Lamagni T., Hunter G., Stimson G. V. et al. Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? Am J Public Health 2001 91 : 38 42.
49. MacDonald M. A., Wodak A. D., Dolan K. A., van Beek I., Cunningham P. H., Kaldor J. M. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust 2000 172 : 57 61.
50. Taylor A., Goldberg D., Hutchinson S., Cameron S., Gore S. M., McMenamin J. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect 2000 40 : 176 183.
51. Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996 86 : 655 661.
52. Hahn J. A., Page-Shafer K., Lum P. J., Bourgois P., Stein E., Evans J. L. et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002 186 : 1558 1564.
53. Rooney G., Gilson R. J. Sexual transmission of hepatitis C virus infection. Sex Transm Infect 1998 74 : 399 404.
54. van de Laar T. J., van der Bij A. K., Prins M., Bruisten S. M., Brinkman K., Ruys T. A. et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 2007 196 : 230 238.
55. Danta M., Brown D., Bhagani S., Pybus O. G., Sabin C. A., Nelson M. et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 2007 21 : 983 991.
56. Hammer G. P., Kellogg T. A., McFarland W. C., Wong E., Louie B., Williams I. et al. Low incidence and prevalence of hepatitis C virus among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000. Sex Transm Dis 2003 30 : 919 924.
57. Matthews G. V., Hellard M., Kaldor J., Lloyd A., Dore G. J. Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al.[Comment]. AIDS 2007 21 : 2112 2113.
58. Nousbaum J. B. Genomic subtypes of hepatitis C virus: epidemiology, diagnosis and clinical consequences. Bull Soc Pathol Exot 1998 91 : 29 33.
59. Kleter B., Brouwer J. T., Nevens F., van Doorn L. J., Elewaut A., Versieck J. et al. Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver 1998 18 : 32 8.
60. Naoumov N. V. Hepatitis C virus infection in Eastern Europe. J Hepatol 1999 31 : 84 7.
61. Viazov S., Kuzin S., Paladi N., Tchernovetsky M., Isaeva E., Mazhul L. et al. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 1997 53 : 36 40.
62. Shustov A. V., Kochneva G. V., Sivolobova G. F., Grazhdantseva A. A., Gavrilova I. V., Akinfeeva L. A. et al. Occurrence of markers, distribution of genotypes and risk factors for viral hepatitis C among some groups of the population in the Novosibirsk region [in Russian]. Zh Mikrobiol Epidemiol Immunobiol 2004 5 : 20 5.
63. Tallo T., Norder H., Tefanova V., Krispin T., Schmidt J., Ilmoja M. et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol 2007 79 : 374 382.
64. Singh A., Goering R. V., Simjee S., Foley S. L., Zervos M. J. Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev 2006 19 : 512 530.
65. Abdul-Quader A. S., Heckathorn D. D., Sabin K., Saidel T. Implementation and analysis of respondent driven sampling: lessons learned from the field. J Urban Health 2006 83 : i1 i5.
66. Vlahov D., Polk B. F. Perspectives on infection with HIV-1 among intravenous drug users. Psychopharmacol Bull 1988 24 : 325 329.
67. Latkin C. A., Vlahov D., Anthony J. C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993 88 : 517 526.
68. Babor T. F., Brown J., Del Boca F. K. Validity of self-reports in applied research on addictive behaviors: fact or fiction? Behav Assess 1990 12 : 5 31.